Tizanidine Tablet
Product Images NDC 72789-326

This is a medication called Tizanidine 050 that comes in a bottle of 30 tablets. The pharmacist recommends dispensing it in a tightly sealed, light-resistant container with a child-resistant closure and storing it between 15°C to 30°C. It should be kept out of reach of children and is marketed and packaged by PD-Rx Pharmaceuticals. Each tablet contains 4.576mg of tizanidine HCI, USP equivalent to 4mg of tizanidine base. The usual dosage is not specified. The product information is available on the package outsert. The GTIN is 00372789325309, and the SNO is AO0A00000006. The expiration date is 02/2025, and the lot number is ACOA0O.*

This is a medication called tizanidine HCI, which comes in tablet form and is dispensed in a child-resistant, light-resistant container according to USP standards. The tablets should be kept at room temperature and out of reach of children. Each tablet contains 2.288mg of tizanidine HCI, equivalent to 2mg of tizanidine base. The usual dosage and complete product information can be found in the package outsert. The medication is interchangeable with tizanidine capsules. It is marketed and packaged by PD-Rx Pharmaceuticals and manufactured by ALKALOIDA Chemical Company in Hungary. The product has a GTIN of 00872789326306, a SNO of AD0DA00000006, an expiration date of 02/2025, and lot number A0DA0O.*

The text is describing improvement in Ashworth Score, possibly in relation to a study or treatment involving a mean dose of 26.8 mg. It mentions different study weeks, including the end of titration, maintenance, and an endpoint that uses the Last Observation Carried Forward method.*